Literature DB >> 22815513

In vivo alterations in calcium buffering capacity in transgenic mouse model of synucleinopathy.

Lidia Reznichenko1, Qun Cheng, Krystal Nizar, Sergey L Gratiy, Payam A Saisan, Edward M Rockenstein, Tanya González, Christina Patrick, Brian Spencer, Paula Desplats, Anders M Dale, Anna Devor, Eliezer Masliah.   

Abstract

Abnormal accumulation of α-synuclein is centrally involved in the pathogenesis of many disorders with Parkinsonism and dementia. Previous in vitro studies suggest that α-synuclein dysregulates intracellular calcium. However, it is unclear whether these alterations occur in vivo. For this reason, we investigated calcium dynamics in transgenic mice expressing human WT α-synuclein using two-photon microscopy. We imaged spontaneous and stimulus-induced neuronal activity in the barrel cortex. Transgenic mice exhibited augmented, long-lasting calcium transients characterized by considerable deviation from the exponential decay. The most evident pathology was observed in response to a repetitive stimulation in which subsequent stimuli were presented before relaxation of calcium signal to the baseline. These alterations were detected in the absence of significant increase in neuronal spiking response compared with age-matched controls, supporting the possibility that α-synuclein promoted alterations in calcium dynamics via interference with intracellular buffering mechanisms. The characteristic shape of calcium decay and augmented response during repetitive stimulation can serve as in vivo imaging biomarkers in this model of neurodegeneration, to monitor progression of the disease and screen candidate treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815513      PMCID: PMC3491088          DOI: 10.1523/JNEUROSCI.1270-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

1.  Coupling of total hemoglobin concentration, oxygenation, and neural activity in rat somatosensory cortex.

Authors:  Anna Devor; Andrew K Dunn; Mark L Andermann; Istvan Ulbert; David A Boas; Anders M Dale
Journal:  Neuron       Date:  2003-07-17       Impact factor: 17.173

2.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

3.  Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.

Authors:  Grace E Stutzmann; Ian Smith; Antonella Caccamo; Salvatore Oddo; Frank M Laferla; Ian Parker
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

4.  Reconstruction of firing rate changes across neuronal populations by temporally deconvolved Ca2+ imaging.

Authors:  Emre Yaksi; Rainer W Friedrich
Journal:  Nat Methods       Date:  2006-05       Impact factor: 28.547

5.  α-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator.

Authors:  Yuangang Zhu; Chunli Duan; Li Lü; Hua Gao; Chunli Zhao; Shun Yu; Kenji Uéda; Piu Chan; Hui Yang
Journal:  Int J Biochem Cell Biol       Date:  2011-02-15       Impact factor: 5.085

6.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

Authors:  E Masliah; E Rockenstein; I Veinbergs; M Mallory; M Hashimoto; A Takeda; Y Sagara; A Sisk; L Mucke
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

Review 7.  Genetic mouse models of Parkinson's disease The state of the art.

Authors:  Iddo Magen; Marie-Françoise Chesselet
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

8.  Number and laminar distribution of neurons in a thalamocortical projection column of rat vibrissal cortex.

Authors:  Hanno S Meyer; Verena C Wimmer; M Oberlaender; Christiaan P J de Kock; Bert Sakmann; Moritz Helmstaedter
Journal:  Cereb Cortex       Date:  2010-06-09       Impact factor: 5.357

9.  Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.

Authors:  Edward Rockenstein; Margaret Mallory; Makoto Hashimoto; David Song; Clifford W Shults; Ingrid Lang; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2002-06-01       Impact factor: 4.164

10.  Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.

Authors:  Roberta Marongiu; Brian Spencer; Leslie Crews; Anthony Adame; Christina Patrick; Margarita Trejo; Bruno Dallapiccola; Enza Maria Valente; Eliezer Masliah
Journal:  J Neurochem       Date:  2009-01-24       Impact factor: 5.372

View more
  20 in total

1.  In vivo stimulus-induced vasodilation occurs without IP3 receptor activation and may precede astrocytic calcium increase.

Authors:  Krystal Nizar; Hana Uhlirova; Peifang Tian; Payam A Saisan; Qun Cheng; Lidia Reznichenko; Kimberly L Weldy; Tyler C Steed; Vishnu B Sridhar; Christopher L MacDonald; Jianxia Cui; Sergey L Gratiy; Sava Sakadzić; David A Boas; Thomas I Beka; Gaute T Einevoll; Ju Chen; Eliezer Masliah; Anders M Dale; Gabriel A Silva; Anna Devor
Journal:  J Neurosci       Date:  2013-05-08       Impact factor: 6.167

2.  Neurovascular Network Explorer 2.0: A Simple Tool for Exploring and Sharing a Database of Optogenetically-evoked Vasomotion in Mouse Cortex In Vivo.

Authors:  Hana Uhlirova; Peifang Tian; Kıvılcım Kılıç; Martin Thunemann; Vishnu B Sridhar; Radim Chmelik; Hauke Bartsch; Anders M Dale; Anna Devor; Payam A Saisan
Journal:  J Vis Exp       Date:  2018-05-04       Impact factor: 1.355

3.  Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

Authors:  Dora Games; Peter Seubert; Edward Rockenstein; Christina Patrick; Margarita Trejo; Kiren Ubhi; Benjamin Ettle; Majid Ghassemiam; Robin Barbour; Dale Schenk; Silke Nuber; Eliezer Masliah
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

Review 4.  Alpha-synuclein modulates dopamine neurotransmission.

Authors:  Brittany Butler; Danielle Sambo; Habibeh Khoshbouei
Journal:  J Chem Neuroanat       Date:  2016-06-19       Impact factor: 3.052

5.  Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506.

Authors:  C R Overk; E Rockenstein; J Florio; Q Cheng; E Masliah
Journal:  Neuroscience       Date:  2015-09-02       Impact factor: 3.590

6.  Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.

Authors:  Edward Rockenstein; Silke Nuber; Cassia R Overk; Kiren Ubhi; Michael Mante; Christina Patrick; Anthony Adame; Margarita Trejo-Morales; Juan Gerez; Paola Picotti; Poul H Jensen; Silvia Campioni; Roland Riek; Jürgen Winkler; Fred H Gage; Beate Winner; Eliezer Masliah
Journal:  Brain       Date:  2014-03-24       Impact factor: 13.501

7.  Identification and quantification of neuronal ensembles in optical imaging experiments.

Authors:  Michael Wenzel; Jordan P Hamm
Journal:  J Neurosci Methods       Date:  2020-12-24       Impact factor: 2.390

Review 8.  Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Gemma Navarro; Annalisa Pinna; Irene Reyes-Resina
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 9.  Complicity of α-synuclein oligomer and calcium dyshomeostasis in selective neuronal vulnerability in Lewy body disease.

Authors:  Kenji Yamamoto
Journal:  Arch Pharm Res       Date:  2021-06-10       Impact factor: 4.946

Review 10.  The benefits of humanized yeast models to study Parkinson's disease.

Authors:  V Franssens; T Bynens; J Van den Brande; K Vandermeeren; M Verduyckt; J Winderickx
Journal:  Oxid Med Cell Longev       Date:  2013-07-01       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.